These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 10627750)

  • 41. Esomeprazole: a review of its use in the management of gastric acid-related diseases in adults.
    McKeage K; Blick SK; Croxtall JD; Lyseng-Williamson KA; Keating GM
    Drugs; 2008; 68(11):1571-607. PubMed ID: 18627213
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Standard therapeutic regimens in H. pylori infection leads to activation of transitory fungal flora in gastric mucus.
    Khomeriki S
    Eksp Klin Gastroenterol; 2014; (5):16-20. PubMed ID: 25518495
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rabeprazole: an update of its use in acid-related disorders.
    Carswell CI; Goa KL
    Drugs; 2001; 61(15):2327-56. PubMed ID: 11772142
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Standarts for diagnosis and treatment of acid and associated with Helicobacter pylori disease (the Fourth Moscow Agreement)].
    Gastroenterological Scientific Society of Russia
    Eksp Klin Gastroenterol; 2010; (5):113-8. PubMed ID: 20731141
    [No Abstract]   [Full Text] [Related]  

  • 45. Helicobacter pylori and peptic ulcer disease.
    Ateshkadi A; Lam NP; Johnson CA
    Clin Pharm; 1993 Jan; 12(1):34-48. PubMed ID: 8428432
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial.
    Schwizer W; Thumshirn M; Dent J; Guldenschuh I; Menne D; Cathomas G; Fried M
    Lancet; 2001 Jun; 357(9270):1738-42. PubMed ID: 11403809
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effects of Helicobacter pylori eradication on gastroesophageal reflux in patients with duodenal ulcer].
    Rollán A; Giancaspero R; Fuster F
    Rev Med Chil; 2002 Feb; 130(2):153-9. PubMed ID: 11974527
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Short-term eradication therapy for Helicobacter pylori does not reduce the incidence of gastric metaplasia in duodenal ulcer patients.
    Rudnicka L; Bobrzyński A; Stachura J
    Pol J Pathol; 1997; 48(2):103-6. PubMed ID: 9278106
    [TBL] [Abstract][Full Text] [Related]  

  • 49. De novo erosive esophagitis in duodenal ulcer patients related to pre-existing reflux symptoms, smoking, and patient age, but not to Helicobacter pylori eradication: a one-year follow-up study.
    Jonaitis L; Kupčinskas J; Kiudelis G; Kupčinskas L
    Medicina (Kaunas); 2010; 46(7):454-9. PubMed ID: 20966617
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Helicobacter pylori and gastrointestinal tract diseases].
    Riis JS; Willoch C; Aase S
    Tidsskr Nor Laegeforen; 1992 Aug; 112(18):2353-5. PubMed ID: 1412235
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of Helicobacter pylori infection in duodenal and gastric ulcer.
    Veldhuyzen van zanten SJ; Lee A
    Curr Top Microbiol Immunol; 1999; 241():47-56. PubMed ID: 10087656
    [No Abstract]   [Full Text] [Related]  

  • 52. [Anti-ulcer therapy after eradication of Helicobacter pylori].
    Imoto I; Taguchi Y
    Nihon Rinsho; 2001 Feb; 59(2):328-32. PubMed ID: 11218407
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ulcer and gastritis.
    Anand BS; Graham DY
    Endoscopy; 1999 Feb; 31(2):215-25. PubMed ID: 10223377
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Helicobacter pylori: changes of indications for eradication therapy].
    Koop H
    Dtsch Med Wochenschr; 2004 Sep; 129 Suppl 2():S91-3. PubMed ID: 15368180
    [No Abstract]   [Full Text] [Related]  

  • 55. [The role of helicobacteriosis in stomach and duodenal lesions].
    Ostrovskiĭ IM
    Ter Arkh; 1998; 70(2):73-6. PubMed ID: 9551581
    [No Abstract]   [Full Text] [Related]  

  • 56. [Quamatel application in three-drug eradication therapy of duodenal ulcer and gastroduodenal ulcerations associated with helicobacter pylori infection].
    Mansurova FKh; Kadyrov DM; Odinaev RI; Ishankulova DM
    Klin Med (Mosk); 2000; 78(6):53-6. PubMed ID: 10900873
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Helicobacter pylori and chronic ulcer disease].
    Gustavsson S; Engstrand L
    Lakartidningen; 1991 Feb; 88(8):624-5. PubMed ID: 2002726
    [No Abstract]   [Full Text] [Related]  

  • 59. [The impact of the degree of Helicobacter pylori semination of the mucous coat of stomach in patients with duodenal ulcer on the infectious organism's eradication].
    Kas'ianenko VI
    Eksp Klin Gastroenterol; 2004; (3):19-23, 102. PubMed ID: 15560395
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Helicobacter pylori and radical therapy for peptic ulcer.
    Bateson MC
    Postgrad Med J; 1995 Nov; 71(841):641-2. PubMed ID: 7494763
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.